Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

scientific article published on 03 July 2020

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2020NatCo..11.3360B
P356DOI10.1038/S41467-020-16991-2
P932PMC publication ID7334216
P698PubMed publication ID32620763

P50authorMaria Luz Martinez ChantarQ71860473
Devin P ChampagneQ88420139
Youdinghuan ChenQ88527808
Brock C ChristensenQ90721354
Beatriz Gomez-SantosQ91022422
Carmelo García-MonzónQ95310280
Mercedes RincónQ97069657
Karen A FortnerQ100958045
Lucía Barbier-TorresQ114293617
Pablo Fernández-TussyQ114293619
Imanol Zubiete-FrancoQ114293620
Marta Varela-ReyQ114293622
Virginia Gutiérrez-de JuanQ117263566
Daniela MestreQ117263606
Juan AnguitaQ40626933
Teresa C DelgadoQ46754800
David Fernández-RamosQ57023045
Paula IruzubietaQ57414546
Patricia AspichuetaQ58112646
P2093author name stringJavier Crespo
Águeda González-Rodríguez
Qian Fang
Frederic Tremblay
Dhaval Oza
Emily Giddings
Felipe Valença-Pereira
P2860cites workNRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE ConsortiumQ21144997
Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionineQ26992163
Knocking down disease: a progress report on siRNA therapeuticsQ28082939
Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signalingQ28118597
MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterationsQ28513253
A central role for JNK in obesity and insulin resistanceQ29619778
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitisQ34023013
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsQ34025149
Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db miceQ34376178
Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspectiveQ34412650
Obesity accelerates epigenetic aging of human liverQ34441968
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum.Q34518314
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugatesQ64083092
Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencingQ86081270
The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute StudiesQ91110914
An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedemaQ93335756
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistanceQ34708975
Proteomic analysis of 4-hydroxynonenal (4-HNE) modified proteins in liver mitochondria from chronic ethanol-fed ratsQ34980950
Regulation of oxidative stress by methylation-controlled J protein controls macrophage responses to inflammatory insultsQ35078589
Genetic and epigenetic regulation of gene expression in fetal and adult human liversQ35302040
Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expressionQ35856811
Mitochondrial complex I plays an essential role in human respirasome assemblyQ35868845
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.Q36365999
Role of mitochondria in non-alcoholic fatty liver diseaseQ36849037
Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancerQ36956157
Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver diseaseQ37248725
JNK at the crossroad of obesity, insulin resistance, and cell stress response.Q37613827
Hepatic RNA Interference: Delivery by Synthetic VectorsQ38200096
DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgeryQ38487123
Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2.Q38636893
Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patientsQ38668121
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategiesQ38705659
Comprehensive and Integrative Genomic Characterization of Hepatocellular CarcinomaQ38722204
Emerging therapies for NASH - the future is now.Q38748157
Oxidative stress and lipotoxicityQ38786583
Respiratory active mitochondrial supercomplexes.Q39913363
Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza VirusQ40656271
The carbon tetrachloride model in miceQ41121854
Hypomethylation and hypermethylation of DNA in Wilms tumors.Q44145932
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury.Q47682393
Current and future pharmacological therapies for NAFLD/NASH.Q47778507
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic DiseasesQ47779219
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity.Q49830924
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA ConjugatesQ49886926
Role of Aramchol in steatohepatitis and fibrosis in mice.Q55135320
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi TherapeuticsQ57094579
Mechanisms of NAFLD development and therapeutic strategies.Q59443140
P433issue1
P921main subjectmetabolic dysfunction–associated steatotic liver diseaseQ1546498
non-alcoholic fatty liverQ66299798
P304page(s)3360
P577publication date2020-07-03
P1433published inNature CommunicationsQ573880
P1476titleSilencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
P478volume11

Search more.